Desenvolvimento e caracterização de sistemas micro e nanoestruturados para a administração cutânea de acetato de dexametasona
Carregando...
Data
2012-06-26
Autores
Oyafuso, Márcia Helena [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Estadual Paulista (Unesp)
Resumo
O acetato de dexametasona (DXM) é um potente anti-inflamatório e imunossupressor utilizado principalmente no tratamento de doenças inflamatórias, auto-imunes e alérgicas; inibindo o acúmulo de células inflamatórias na zona de inflamação. A DXM promove uma série de efeitos colaterais sistêmicos, sobretudo a Síndrome de Cushing. Dessa forma, sua aplicação tópica pode ser conveniente de forma a localizá-lo no seu sítio de ação, evitando-se efeitos adversos sistêmicos. O polioxietileno 20 cetil éter forma sistemas de fase hexagonal e cúbica em contato com água. Os sistemas microemulsionados e líquido-cristalinos de fase hexagonal e cúbica têm demonstrado grande vantagem na liberação tópica de várias substâncias dada às características de interação com o estrato córneo e outras camadas da pele. Os objetivos desta pesquisa foram desenvolver e caracterizar sistemas micro e nanoestruturados acrescidos de DXM. Foram desenvolvidos sistemas empregando água, polieoxietileno 20 cetil éter e polieter funcional siloxano. Após delimitação das regiões, foram selecionados alguns sistemas de fase hexagonal e cúbica e um sistema microemulsionado para incorporação do fármaco. A caracterização do sistema foi realizada empregando microscopia de luz polarizada (MLP), espalhamento de raios-X de baixo ângulo (SAXS) e reologia. Realizaram-se ensaios de validação de metodologia analítica para quantificação de DXM por CLAE, comprovando que o método foi linear, exato e preciso. Os ensaios de SAXS corroboram com os de MLP e com as características reológicas dos sistemas, que evidenciaram que as microemulsões apresentaram módulo de perda maior que módulo elástico, resultando em um sistema pouco estruturado quando comparado às formulações...
The dexamethasone acetate (DXM) is a potent anti-inflammatory and immunosuppressive drug used mainly in the treatment of inflammatory diseases, autoimmune and allergic reactions, inhibiting the accumulation of inflammatory cells in the inflammation area. The DXM promotes a number of systemic side effects, especially Cushing's syndrome. Thus, topical application may be appropriate in order to find it on it site of action, avoiding systemic adverse effects. The polyoxyethylene 20 cetyl ether forms hexagonal and cubic phase systems in contact with water. The microemulsion and liquid-crystalline phase of hexagonal and cubic system have shown great advantage in topical delivery of various substances given to the characteristics of interaction with the stratum corneum and other skin layers. The objectives of this research were to develop and characterize micro- and nanostructured systems containing DXM. Systems have been developed using water, polyoxyethylene 20 cetyl ether and polyether functional siloxane. After defining the regions, some hexagonal and cubic phase systems and a microemulsion system were selected for incorporation of the drug. The system characterization was carried out using polarized light microscopy (MLP), SAXS and rheology. Validation assays of analytical methodology were performed for quantification of DXM by HPLC, showing that the method was linear, accurate and precise. The SAXS experiments corroborate with the MLP and the rheological characteristics of the systems, which showed that the microemulsions had loss modulus greater than the elastic modulus, resulting in a less structured system when compared... (Complete abstract click electronic access below)
The dexamethasone acetate (DXM) is a potent anti-inflammatory and immunosuppressive drug used mainly in the treatment of inflammatory diseases, autoimmune and allergic reactions, inhibiting the accumulation of inflammatory cells in the inflammation area. The DXM promotes a number of systemic side effects, especially Cushing's syndrome. Thus, topical application may be appropriate in order to find it on it site of action, avoiding systemic adverse effects. The polyoxyethylene 20 cetyl ether forms hexagonal and cubic phase systems in contact with water. The microemulsion and liquid-crystalline phase of hexagonal and cubic system have shown great advantage in topical delivery of various substances given to the characteristics of interaction with the stratum corneum and other skin layers. The objectives of this research were to develop and characterize micro- and nanostructured systems containing DXM. Systems have been developed using water, polyoxyethylene 20 cetyl ether and polyether functional siloxane. After defining the regions, some hexagonal and cubic phase systems and a microemulsion system were selected for incorporation of the drug. The system characterization was carried out using polarized light microscopy (MLP), SAXS and rheology. Validation assays of analytical methodology were performed for quantification of DXM by HPLC, showing that the method was linear, accurate and precise. The SAXS experiments corroborate with the MLP and the rheological characteristics of the systems, which showed that the microemulsions had loss modulus greater than the elastic modulus, resulting in a less structured system when compared... (Complete abstract click electronic access below)
Descrição
Palavras-chave
Cristais líquidos, Acetatos, Fármacos, Microscopia de polarização, Raios X - Espalhamento a baixo angulo
Como citar
OYAFUSO, Márcia Helena. Desenvolvimento e caracterização de sistemas micro e nanoestruturados para a administração cutânea de acetato de dexametasona. 2012. 87 f. Dissertação (mestrado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Ciências Farmacêuticas, 2012.